MedDataX Logo

Metabolic Syndrome Prevalence Study

NCT ID: NCT02379702

Last Updated: 2015-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1659 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cluster Analysis to Identify Metabolic Syndrome Components and Physical Fitness in Patients With Metabolic Syndrome

NCT05569642

Metabolic Syndrome
COMPLETED

Diet Quality And Metabolic Syndrome In Adult Individuals: Evaluation Of Turkey Nutrition And Health Survey 2017

NCT06976970

Metabolic Syndrome
ACTIVE_NOT_RECRUITING

Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)

NCT05702437

Metabolic Syndrome
RECRUITING

Determination Physical Activity Levels,Quality Life,Depression and Fatigue Severity Individuals With Metabolic Syndrome

NCT05184634

Metabolic Syndrome
COMPLETED NA

Regional Observation of the Metabolic Syndrome

NCT00874952

Metabolic Syndrome
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Metabolic Syndrome

This study will provide important information on the social and economic dimensions of metabolic syndrome

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteers who participated in the METSAR-I study in 2003
* Patients who accepted to participate will be included the second follow up phase.

Exclusion Criteria

None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abdi Ibrahim Ilac San. ve Tic A.S.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Omer Kozan

Role: STUDY_DIRECTOR

Dokuz Eylul University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara University

Ankara, , Turkey (Türkiye)

Site Status

Gazi University

Ankara, , Turkey (Türkiye)

Site Status

Yuksek Ihtisas Hospital

Ankara, , Turkey (Türkiye)

Site Status

Istanbul Cerrahpasa University

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Medeniyet University

Istanbul, , Turkey (Türkiye)

Site Status

Prof. Dr. Omer Kozan

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

METSAR-II

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prevalence of Metabolic Syndrome in Atahualpa
NCT01770054 COMPLETED
Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults
NCT01594710 COMPLETED
Effectiveness of MD on MetS Patients
NCT06961682 NOT_YET_RECRUITING NA
Investigation of Respiratory Functions, Exercise Endurance and Functional Capacity in Geriatric Individuals With Metabolic Syndrome
NCT06253819 COMPLETED
Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery.
NCT06645730 ACTIVE_NOT_RECRUITING
An Observational Study of Patients With Metabolic Syndrome and Related Conditions
NCT05842811 NOT_YET_RECRUITING
Effect of a Low Glycemic Index on Metabolic Syndrome
NCT02356952 COMPLETED NA
a Population Based Study on Metabolic Syndrome Complications, and Mortality
NCT02958579 UNKNOWN
Serum Concentrations, Physical and Psychological Well-being in Metabolic Syndrome
NCT03338868 UNKNOWN
Impact of Medical Nutrition Therapy and Follow-Up Frequency on Metabolic Syndrome Parameters
NCT06813131 COMPLETED NA
Metabolic Syndrome Cohort in Korea
NCT02077530 WITHDRAWN
Metabolic FingerPrinting
NCT05305729 RECRUITING
Prospective Metabolic Indicator Study
NCT03588117 COMPLETED
Metabolic Syndrome Observation on a Regional Basis
NCT00933010 COMPLETED
Retrospective Analysis for Patients With Metabolic Syndrome
NCT06182618 RECRUITING
Fertility and Cardiovascular Risk in Men With Metabolic Syndrome
NCT03977064 UNKNOWN NA
Remote Physical Activity Monitoring in Individuals With Metabolic Syndrome
NCT05592704 COMPLETED NA
The Effect of Feedback on Physical Activity Surveillance Using Wearable Device-Smartphone Application for Resolution of Metabolic Syndrome in Aged 60 or Older
NCT05830552 COMPLETED NA
Metabolic Syndrome Feasibility Study
NCT02287766 COMPLETED
The Reversal Intervention for Metabolic Syndrome Study
NCT01043770 COMPLETED NA
Mobile Health (M-health) Intervention to Reduce the Epigenetic Signature in Metabolic Syndrome (MetS)
NCT06448806 COMPLETED NA
MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
NCT07312136 ENROLLING_BY_INVITATION
Regional Observatory on Metabolic Syndrome- LAZIO
NCT00689455 COMPLETED
Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status Communities
NCT02459249 UNKNOWN NA
Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.
NCT05477394 COMPLETED